Table 2 |
||||||||||||||
|
Assessment of methodological quality of randomised trials: |
||||||||||||||
|
Paper |
Nobaek 2000 |
O Sullivan 2000 |
Niedzelin 2001 |
Kim 2003 |
Saggioro 2004 |
Kajander 2006 |
O' mahoney 2005 |
Gawronska 2007 |
Bausserman 2005 |
Whorwell 2006 |
Niv 2005 |
Kim 2005 |
Guyonnet 2007 |
Gade 1989 |
|
|
||||||||||||||
|
Randomization |
- |
- |
- |
- |
- |
+ |
+ |
+ |
+ |
- |
- |
- |
+* |
+ |
|
Concealment of Allocation |
- |
+ |
- |
- |
- |
+ |
+ |
+ |
+ |
- |
- |
- |
+* |
+ |
|
Double Blinding |
+ |
+ |
- |
+ |
- |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+* |
+ |
|
Intention to treat |
- |
+ |
+ |
+ |
+ |
- |
+ |
+ |
- |
+ |
+ |
+ |
+ |
+ |
|
Total |
1 |
3 |
1 |
2 |
1 |
3 |
4 |
4 |
3 |
2 |
2 |
2 |
4* |
4 |
|
|
||||||||||||||
|
+ Clear reporting of the methodological quality - Not clear from the paper * Clarified after emailing author |
||||||||||||||
|
Hoveyda et al. BMC Gastroenterology 2009 9:15 doi:10.1186/1471-230X-9-15 |
||||||||||||||
